Recent Advances in The Treatment of Multiple Myeloma: Expert and Patient Perspectives - Episode 5

Available Induction Treatment Regimens for Patients with Transplant-Ineligible MM

January 10, 2023

Shaji Kumar, MD, Krina K. Patel, MD, MSc, University of Texas MD Anderson Cancer Center

Shaji Kumar, MD, and Krina Patel, MD, discuss the treatment options for patients with newly-diagnosed multiple myeloma who are not eligible for stem cell transplant.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Induction Regimen Options for Patients with Transplant-Eligible Newly-Diagnosed Multiple Myeloma (NDMM)

EP. 2: Introduction to Multiple Myeloma and Resources for Patient Education after Diagnosis

EP. 3: The Role of Stem Cell Transplant in the NDMM Treatment Landscape

EP. 4: Optimal Treatment Selection for Patients with NDMM: Updates from IMS 2022

Now Viewing

EP. 5: Available Induction Treatment Regimens for Patients with Transplant-Ineligible MM

EP. 6: Key Considerations for Patients with Multiple Myeloma During the Treatment Journey

EP. 7: Treatment Options for MM at Early Relapse

EP. 8: Unmet Needs in the Treatment of NDMM and R/R MM and Clinical Pearls for Community Oncologists